In addition, CUR reduced the intranuclear expression of NF-κB p65 by inhibiting the phosphorylation of IκBα and its degradation, thereby inhibiting NF-κB activation, which plays a key role in the inhibition of osteoclast genesis in rheumatoid arthritis patients. The gene discussed is NFKB1; the disease is rheumatoid arthritis.